Skip to main content

Currently Skimming:

Summary
Pages 1-10

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... There is a growing belief that no specific causal factor or agent will be identified. Many thousands of Gulf War veterans1 who have CMI live with sometimes debilitating symptoms and seek an effective way to manage their symp 1  Veterans are considered to have served in the Gulf War if they were on active military duty in the Southwest Asia theater of military operations during the period from the 1991 Gulf War (Operation Desert Storm)
From page 2...
... Information sources to pursue could include, but are not limited to: •  ublished peer-reviewed literature concerning the treatment of multi­ P symptom illness among the 1991 Gulf War veteran population; •  ublished peer-reviewed literature concerning treatment of multi­ P symptom illness among Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn active-duty service mem bers and veterans; •  ublished peer-reviewed literature concerning treatment of multi P symptom illness among similar populations such as allied military personnel; and •  ublished peer-reviewed literature concerning treatment of popula P tions with a similar constellation of symptoms. In addition to summarizing the available scientific and medical litera ture regarding the best treatments for chronic multisymptom illness among Gulf War veterans, the IOM will:
From page 3...
... 4. Improving the collection and quality of data on outcomes and satisfaction of care for veterans who have CMI and are treated in VA health care facilities.
From page 4...
... On the basis of the evidence reviewed, the committee cannot recommend any specific therapy as a set treatment for veterans who have CMI. However, for the reasons outlined below, the committee believes that a "one-size-fits-all" approach is not effective for managing veterans who have CMI and that individualized health care management plans are necessary.
From page 5...
... The Department of Veterans Affairs should include in its electronic health record a "pop-up" screen to prompt clini cians to ask questions about whether a patient has symptoms consistent with the committee's definition of chronic multi­ ymptom illness. s Once a veteran has been identified as having CMI and has entered the VA health care system, the next step is to provide comprehensive care for the veteran, not only for CMI but also for any comorbid conditions.
From page 6...
... Recommendation 8-5. The Department of Veterans Affairs should c ­ ommit the resources needed to ensure that patient-aligned care teams have the time and skills required to meet the needs of veterans who have chronic multisymptom illness as specified in the veterans' integrated personal care plans, that the adequacy of time for clinical encounters is measured routinely, and that clinical case loads are adjusted in response to the data generated by measurements.
From page 7...
... The Department of Veterans Affairs (VA) should provide resources for and designate "chronic multisymptom illness champions" at each VA medical center.
From page 8...
... should provide the resources needed to expand its data collection efforts to include a national system for the robust capture, aggregation, and analysis of data on the structures, processes, and outcomes of care delivery and on the satisfaction with care among patients who have chronic multisymptom illness so that gaps in clinical care can be evaluated, strategies for improve ment can be planned, long-term outcomes of treatment can be assessed, and this information can be disseminated to VA health care facilities. Research Recommendations The committee's research recommendations are in two categories: treatments for CMI and research needs related to program evaluation.
From page 9...
... Examples of methodologic and reporting guidelines include those set forth by such organizations as the Agency for Healthcare Research and Quality and the Institute of Medicine and in such other efforts as the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and the Consolidated Standards of Reporting Trials statement. On the basis of its assessment of the evidence on treatments for CMI, the committee found that several treatments and treatment approaches may be potentially useful for CMI.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.